Your location:Home page > Program
Search:
All Dates (UTC+8):
  • All
  • 2024-06-06 [Thursday]
  • 2024-06-07 [Friday]
  • 2024-06-08 [Saturday]
All Rooms:
  • All
  • Watson Auditorium
  • Exhibition Area - II
  • Exhibition Area - III
  • Meeting room - M1
  • Meeting Room - M2
  • Meeting Room - M3
  • Meeing Room-M4
  • Meeting Room - M5
  • Meeting room - M9

2024-06-08 Saturday

Meeting Room - M2 (UTC+8)

10:00-12:05 (UTC+8) | i-liver-Breakthroughs in Liver Cancer Therapy
Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
10:00-10:05

Opening Remarks

Gao-Jun Teng Zhongda Hospital, Southeast University, China
10:05-10:25

Pushing the Envelope for Surgical Management of Advanced Hepatocellular Carcinoma

Junichi Shindoh Toranomon Hospital Tokyo Japan, Japan
10:25-10:45

2024 ASCO new progress of liver cancer research

Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China, China
10:45-11:05

Panel Discussion

Guang-Shao Cao Henan Provincial Peoples Hospital, China / Qi Ling The First Affiliated Hospital, Zhejiang University School of Medicine, China / Ji-Zhou Wang The First Affiliated Hospital of University of Science and Technology of China, China
11:05-11:25

Real-world data for Ate/Bev in unresectable HCC

Hong Jae Chon CHA Bundang Medical Center, CHA University, Korea
11:25-11:45

Emerging immunotherapy for HCC: the end of beginning

Qiang Gao Zhongshan Hospital Fudan University, China
11:45-12:05

Panel discussion

Xue-Feng Luo West China Hospital, Sichuan University, China / Jun Luo Zhejiang Cancer Hospital, China / Jian-Jun Han Shandong Cancer Hospital, China
12:45-14:45 (UTC+8) | 2024年肝癌全国专家咨询会
15:00-17:20 (UTC+8) | CHANCE研究
Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
15:00-15:05

主席致辞

滕皋军 东南大学附属中大医院
15:05-15:15

"一项比较精细超选择TACE与非精细超选择TACE治疗肝细胞癌 有效性的全国多中心真实世界研究(CHANCE2403)"

仲斌演 苏州大学附属第一医院
15:15-15:25

方案讨论

15:25-15:35

"TACE+消融系列研究 1.《TACE+消融针对BCLC-A期肝癌多中心真实世界研究》 2.《TACE+消融针对BCLC-B期肝癌多中心真实世界研究》 3.《TACE+消融针对肝内高危区域肝癌病灶多中心真实世界研究》"

王健 北京大学第一医院
15:35-15:45

方案讨论

15:45-15:55

CTACE/DTACE+HAIC对比HAIC联合系统治疗的真实世界研究(CHANCE2404)

刘宝将 北京大学肿瘤医院
15:55-16:05

方案讨论

16:05-16:15

BACE联合静脉化疗用于一线经免疫治疗失败的晚期NSCLC的疗效与安全性:一项前瞻性、多中心、非干预性临床研究(CHANCE2406)

涂建飞 丽水市中心医院
16:15-16:25

方案讨论

16:25-16:35

肝细胞癌 TACE 后肝脓肿形成的预测及预后 分析:一项回顾性多中心巢式病例对照研究(CHANCE2407)

畅智慧 中国医科大学附属盛京医院
16:35-16:45

方案讨论

16:45-16:55

"序贯对比同期TACE联合PD-1/PDL1抑制剂及抗血管生成药物治疗肝细胞癌的全国多中心真实世界研究(CHANCE2401) "

陈建建 东南大学附属中大医院
16:55-17:05

方案讨论

17:05-17:15

讨论:如何共创以CHANCE为背景的科研新生态

17:15-17:20

会议总结

滕皋军 东南大学附属中大医院